Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
70.39 USD
0.1%
Market Closed
Updated:
May 12, 2024
Prestige Consumer Healthcare Inc
Total Liabilities & Equity
|
Prestige Consumer Healthcare Inc
Total Liabilities & Equity Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Total Liabilities & Equity
$3.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Liabilities & Equity
$172B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Liabilities & Equity
$99B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
23%
|
CAGR 10-Years
11%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Liabilities & Equity
$226.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Liabilities & Equity
$105.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
0%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Liabilities & Equity
$63.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
See Also
What is Prestige Consumer Healthcare Inc's Total Liabilities & Equity?
Total Liabilities & Equity
3.3B
USD
3.3B
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Total Liabilities & Equity amounts to 3.3B USD.
What is Prestige Consumer Healthcare Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
6%
6%
Over the last year, the Total Liabilities & Equity growth was -11%. The average annual Total Liabilities & Equity growth rates for Prestige Consumer Healthcare Inc have been -1% over the past three years , -2% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
